 Christopher Schneck
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bipolar Disorder | 31 | 2023 | 203 | 5.870 |
Why?
| | Depressive Disorder, Major | 9 | 2023 | 301 | 2.200 |
Why?
| | Family Therapy | 19 | 2023 | 62 | 2.070 |
Why?
| | Affect | 12 | 2023 | 246 | 1.320 |
Why?
| | Telemedicine | 6 | 2020 | 662 | 1.170 |
Why?
| | Mental Health Services | 4 | 2020 | 316 | 0.930 |
Why?
| | Estrogen Antagonists | 1 | 2020 | 39 | 0.700 |
Why?
| | Tamoxifen | 1 | 2020 | 190 | 0.660 |
Why?
| | Behavioral Symptoms | 2 | 2017 | 41 | 0.660 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2020 | 138 | 0.660 |
Why?
| | Mood Disorders | 5 | 2023 | 112 | 0.510 |
Why?
| | Antipsychotic Agents | 8 | 2017 | 183 | 0.460 |
Why?
| | Cognition | 1 | 2020 | 990 | 0.430 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 4 | 2021 | 363 | 0.410 |
Why?
| | Adolescent | 26 | 2023 | 17800 | 0.400 |
Why?
| | Algorithms | 2 | 2017 | 1469 | 0.360 |
Why?
| | Psychotherapy, Brief | 3 | 2020 | 27 | 0.350 |
Why?
| | Anxiety Disorders | 5 | 2021 | 304 | 0.350 |
Why?
| | Depressive Disorder | 4 | 2011 | 330 | 0.310 |
Why?
| | Humans | 44 | 2023 | 114045 | 0.300 |
Why?
| | Family Conflict | 4 | 2022 | 36 | 0.290 |
Why?
| | Depression | 5 | 2023 | 1133 | 0.290 |
Why?
| | Psychiatric Status Rating Scales | 5 | 2017 | 481 | 0.280 |
Why?
| | Mental Health | 3 | 2020 | 559 | 0.260 |
Why?
| | Treatment Outcome | 14 | 2023 | 9049 | 0.250 |
Why?
| | Pandemics | 3 | 2020 | 1310 | 0.230 |
Why?
| | Depressive Disorder, Treatment-Resistant | 1 | 2023 | 4 | 0.220 |
Why?
| | Anhedonia | 1 | 2023 | 9 | 0.220 |
Why?
| | Child | 11 | 2022 | 18401 | 0.210 |
Why?
| | Anticipation, Psychological | 1 | 2023 | 18 | 0.210 |
Why?
| | Family Relations | 3 | 2020 | 85 | 0.210 |
Why?
| | Female | 23 | 2023 | 59324 | 0.210 |
Why?
| | Comorbidity | 4 | 2019 | 1447 | 0.200 |
Why?
| | Ketamine | 1 | 2023 | 92 | 0.200 |
Why?
| | Patient Education as Topic | 5 | 2017 | 666 | 0.200 |
Why?
| | Age of Onset | 4 | 2011 | 444 | 0.200 |
Why?
| | Antidepressive Agents | 3 | 2009 | 195 | 0.190 |
Why?
| | Amygdala | 1 | 2023 | 171 | 0.190 |
Why?
| | Nucleus Accumbens | 1 | 2023 | 124 | 0.190 |
Why?
| | Reward | 1 | 2023 | 211 | 0.180 |
Why?
| | Feedback | 1 | 2020 | 144 | 0.170 |
Why?
| | Combined Modality Therapy | 5 | 2023 | 1117 | 0.170 |
Why?
| | Ericales | 1 | 1998 | 2 | 0.160 |
Why?
| | Suicidal Ideation | 2 | 2020 | 402 | 0.160 |
Why?
| | Outpatients | 2 | 2020 | 325 | 0.160 |
Why?
| | Panic Disorder | 1 | 1998 | 20 | 0.160 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2018 | 56 | 0.150 |
Why?
| | Phytotherapy | 1 | 1998 | 67 | 0.150 |
Why?
| | House Calls | 1 | 2019 | 115 | 0.150 |
Why?
| | Psychiatry | 1 | 2020 | 154 | 0.150 |
Why?
| | Kidney Failure, Chronic | 1 | 2023 | 489 | 0.150 |
Why?
| | Male | 20 | 2023 | 55396 | 0.150 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2009 | 230 | 0.140 |
Why?
| | Kidney Transplantation | 1 | 2023 | 538 | 0.140 |
Why?
| | Ambulatory Care | 1 | 2020 | 479 | 0.140 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 459 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2023 | 944 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 675 | 0.120 |
Why?
| | Medication Adherence | 1 | 2019 | 531 | 0.120 |
Why?
| | Movement Disorders | 1 | 2015 | 48 | 0.120 |
Why?
| | Psychotropic Drugs | 4 | 2020 | 54 | 0.120 |
Why?
| | Risk Factors | 5 | 2013 | 8614 | 0.120 |
Why?
| | Irritable Mood | 2 | 2019 | 48 | 0.120 |
Why?
| | Anti-HIV Agents | 1 | 2019 | 663 | 0.110 |
Why?
| | Expressed Emotion | 2 | 2013 | 17 | 0.110 |
Why?
| | Diagnosis, Differential | 2 | 2009 | 1331 | 0.100 |
Why?
| | Mental Disorders | 1 | 2019 | 889 | 0.100 |
Why?
| | Sex Factors | 2 | 2009 | 1706 | 0.100 |
Why?
| | Risk Assessment | 2 | 2017 | 2958 | 0.090 |
Why?
| | Psychotherapy | 2 | 2019 | 149 | 0.090 |
Why?
| | Severity of Illness Index | 3 | 2011 | 2537 | 0.090 |
Why?
| | Retrospective Studies | 4 | 2020 | 12521 | 0.090 |
Why?
| | Quality of Life | 2 | 2019 | 2343 | 0.090 |
Why?
| | Phenotype | 1 | 2017 | 2784 | 0.080 |
Why?
| | Disease Progression | 2 | 2020 | 2371 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4595 | 0.080 |
Why?
| | Euphoria | 1 | 2009 | 3 | 0.080 |
Why?
| | Hostility | 1 | 2009 | 13 | 0.080 |
Why?
| | Thinking | 1 | 2009 | 51 | 0.080 |
Why?
| | Anticonvulsants | 2 | 2008 | 178 | 0.070 |
Why?
| | Problem Solving | 3 | 2017 | 145 | 0.070 |
Why?
| | Drug Therapy, Combination | 2 | 2009 | 949 | 0.070 |
Why?
| | Cohort Studies | 2 | 2008 | 4883 | 0.070 |
Why?
| | Secondary Prevention | 1 | 2008 | 221 | 0.070 |
Why?
| | Models, Psychological | 1 | 2008 | 297 | 0.060 |
Why?
| | Lithium Compounds | 1 | 2006 | 9 | 0.060 |
Why?
| | Valproic Acid | 1 | 2006 | 43 | 0.060 |
Why?
| | Prospective Studies | 2 | 2008 | 6195 | 0.060 |
Why?
| | HIV Infections | 1 | 2019 | 2453 | 0.060 |
Why?
| | Patient Care Management | 1 | 2006 | 53 | 0.060 |
Why?
| | Critical Pathways | 1 | 2006 | 76 | 0.060 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2004 | 35 | 0.060 |
Why?
| | Motor Activity | 1 | 2009 | 635 | 0.060 |
Why?
| | Anxiety | 2 | 2021 | 843 | 0.060 |
Why?
| | Lithium | 1 | 2023 | 36 | 0.050 |
Why?
| | Communication | 3 | 2017 | 734 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2009 | 4392 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2023 | 370 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 4402 | 0.050 |
Why?
| | Adult | 4 | 2020 | 30375 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2023 | 199 | 0.050 |
Why?
| | Waiting Lists | 1 | 2023 | 206 | 0.050 |
Why?
| | Living Donors | 1 | 2023 | 270 | 0.050 |
Why?
| | Age Factors | 1 | 2008 | 2885 | 0.040 |
Why?
| | Family Health | 2 | 2013 | 193 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2023 | 926 | 0.040 |
Why?
| | Executive Function | 1 | 2023 | 380 | 0.040 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 65 | 0.040 |
Why?
| | Animals | 1 | 2020 | 31565 | 0.040 |
Why?
| | Food, Organic | 1 | 1998 | 2 | 0.040 |
Why?
| | Organophosphates | 1 | 2019 | 90 | 0.040 |
Why?
| | Sertraline | 1 | 1998 | 26 | 0.040 |
Why?
| | Prevalence | 1 | 2004 | 2247 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2384 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 345 | 0.040 |
Why?
| | Adenine | 1 | 2019 | 218 | 0.040 |
Why?
| | Viral Load | 1 | 2019 | 405 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2020 | 735 | 0.040 |
Why?
| | Prodromal Symptoms | 1 | 2017 | 11 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2019 | 410 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 122 | 0.030 |
Why?
| | Substance-Related Disorders | 1 | 2004 | 942 | 0.030 |
Why?
| | Mothers | 1 | 2021 | 650 | 0.030 |
Why?
| | Patient Compliance | 2 | 2011 | 524 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 945 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1360 | 0.030 |
Why?
| | Videoconferencing | 1 | 2015 | 57 | 0.030 |
Why?
| | Emotions | 1 | 2018 | 474 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2764 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1175 | 0.030 |
Why?
| | Early Medical Intervention | 1 | 2013 | 52 | 0.020 |
Why?
| | Research | 1 | 2015 | 389 | 0.020 |
Why?
| | Parents | 1 | 2020 | 1181 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3397 | 0.020 |
Why?
| | Antimanic Agents | 1 | 2009 | 14 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 26605 | 0.020 |
Why?
| | Education | 1 | 2009 | 93 | 0.020 |
Why?
| | Convalescence | 1 | 2008 | 15 | 0.020 |
Why?
| | Young Adult | 1 | 2023 | 10444 | 0.020 |
Why?
| | Recurrence | 1 | 2008 | 925 | 0.020 |
Why?
| | Time Factors | 1 | 2014 | 6077 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2011 | 2090 | 0.010 |
Why?
| | Adolescent Behavior | 1 | 2004 | 486 | 0.010 |
Why?
|
|
Schneck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|